Michelin & GM Develop New Generation of Airless Wheel Technology

Michelin and General Motors presented a new generation of airless wheel technology, the MICHELIN Uptis Prototype (or “Unique Puncture-proof Tire System”), at the Movin’On Summit for sustainable mobility. GM intends to develop this airless wheel assembly with Michelin and aims to introduce it on passenger vehicles as early as 2024.

Michelin Uptis Prototype

Later this year, GM will initiate real-world testing and validation of the Uptis Prototype on a Michigan test fleet of Chevrolet Bolt EVs.

“General Motors is excited about the possibilities that Uptis presents, and we are thrilled to collaborate with Michelin on this breakthrough technology,” said Steve Kiefer, senior vice president, Global Purchasing and Supply Chain, General Motors. “Uptis is an ideal fit for propelling the automotive industry into the future and a great example of how our customers benefit when we collaborate and innovate with our supplier partners.”

Airless Technology

Airless technology makes the Uptis Prototype eliminate flats and blowouts. This means Uptis offers significant potential for reducing the use of raw materials and waste, contributing to GM’s vision for a world with zero crashes, zero emissions and zero congestion as it:

  • Reduces the number of punctured or damaged tires that are scrapped before reaching the end of their life cycle.
  • Reduces the use of raw materials, energy for production and emissions linked to the manufacture of spare tires and replacement tires that are no longer required.
  • Lasts longer by eliminating irregular wear and tear caused by over- or under-inflation.
  • Reduces dangers related to flats and blowouts.

Source: https://www.gm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.